![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/02 | (2006.01) |
C07D 471/04 | (2013.01) | ||
C07D 471/04 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61K 31/506 | (2006.01) | ||
C07D 403/04 | (2013.01) | ||
A61K 31/437 | (2006.01) | ||
C07D 401/04 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07D 401/14 | (2013.01) | ||
C07D 487/10 | (2013.01) | ||
C07D 401/02 | (2013.01) |
(11) | Number of the document | 3686193 |
(13) | Kind of document | T |
(96) | European patent application number | 20157798.8 |
Date of filing the European patent application | 2012-07-25 | |
(97) | Date of publication of the European application | 2020-07-29 |
(45) | Date of publication and mention of the grant of the patent | 2022-03-02 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201161512061 P | 2011-07-27 | US | |
201261591363 P | 2012-01-27 | US |
(72) |
BUTTERWORTH, Sam , GB
WARD, Richard Andrew , GB
FINLAY, Maurice Raymond Verschoyle , GB
KADAMBAR, Vasantha, Krishna , GB
CHINTAKUNTLA, Chandrasekhara, Reddy , GB
MURUGAN, Andiappan , GB
CHUAQUI, Claudio, Edmundo , US
REDFEARN, Heather, Marie , GB
|
(73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
(54) | 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS |
2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS |